NATIONAL RESEARCH CORP (NRC) Stock Fundamental Analysis

NASDAQ:NRC • US6373722023

13.88 USD
+0.03 (+0.22%)
Last: Mar 3, 2026, 12:01 PM
Fundamental Rating

5

NRC gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 101 industry peers in the Health Care Providers & Services industry. NRC has an excellent profitability rating, but there are some minor concerns on its financial health. NRC has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

  • In the past year NRC was profitable.
  • In the past year NRC had a positive cash flow from operations.
  • In the past 5 years NRC has always been profitable.
  • Each year in the past 5 years NRC had a positive operating cash flow.
NRC Yearly Net Income VS EBIT VS OCF VS FCFNRC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M

1.2 Ratios

  • NRC's Return On Assets of 8.60% is amongst the best of the industry. NRC outperforms 92.08% of its industry peers.
  • Looking at the Return On Equity, with a value of 82.92%, NRC belongs to the top of the industry, outperforming 97.03% of the companies in the same industry.
  • With an excellent Return On Invested Capital value of 16.19%, NRC belongs to the best of the industry, outperforming 93.07% of the companies in the same industry.
  • The Average Return On Invested Capital over the past 3 years for NRC is significantly above the industry average of 9.12%.
  • The 3 year average ROIC (24.89%) for NRC is well above the current ROIC(16.19%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 8.6%
ROE 82.92%
ROIC 16.19%
ROA(3y)17.53%
ROA(5y)20.14%
ROE(3y)75.13%
ROE(5y)62.68%
ROIC(3y)24.89%
ROIC(5y)29.78%
NRC Yearly ROA, ROE, ROICNRC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50 100 150

1.3 Margins

  • NRC's Profit Margin of 8.44% is amongst the best of the industry. NRC outperforms 89.11% of its industry peers.
  • NRC's Profit Margin has declined in the last couple of years.
  • NRC's Operating Margin of 16.44% is amongst the best of the industry. NRC outperforms 95.05% of its industry peers.
  • In the last couple of years the Operating Margin of NRC has declined.
  • NRC has a Gross Margin of 61.88%. This is amongst the best in the industry. NRC outperforms 82.18% of its industry peers.
  • NRC's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 16.44%
PM (TTM) 8.44%
GM 61.88%
OM growth 3Y-25.59%
OM growth 5Y-12.28%
PM growth 3Y-26.17%
PM growth 5Y-21.27%
GM growth 3Y-0.24%
GM growth 5Y-0.39%
NRC Yearly Profit, Operating, Gross MarginsNRC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60

4

2. Health

2.1 Basic Checks

  • NRC has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
  • Compared to 1 year ago, NRC has less shares outstanding
  • The number of shares outstanding for NRC has been reduced compared to 5 years ago.
  • Compared to 1 year ago, NRC has a worse debt to assets ratio.
NRC Yearly Shares OutstandingNRC Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M 25M
NRC Yearly Total Debt VS Total AssetsNRC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M

2.2 Solvency

  • An Altman-Z score of 2.80 indicates that NRC is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • The Altman-Z score of NRC (2.80) is better than 62.38% of its industry peers.
  • The Debt to FCF ratio of NRC is 5.02, which is a neutral value as it means it would take NRC, 5.02 years of fcf income to pay off all of its debts.
  • NRC has a better Debt to FCF ratio (5.02) than 63.37% of its industry peers.
  • A Debt/Equity ratio of 5.36 is on the high side and indicates that NRC has dependencies on debt financing.
  • NRC's Debt to Equity ratio of 5.36 is on the low side compared to the rest of the industry. NRC is outperformed by 78.22% of its industry peers.
Industry RankSector Rank
Debt/Equity 5.36
Debt/FCF 5.02
Altman-Z 2.8
ROIC/WACC2.09
WACC7.75%
NRC Yearly LT Debt VS Equity VS FCFNRC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M

2.3 Liquidity

  • A Current Ratio of 0.55 indicates that NRC may have some problems paying its short term obligations.
  • NRC has a Current ratio of 0.55. This is amonst the worse of the industry: NRC underperforms 86.14% of its industry peers.
  • NRC has a Quick Ratio of 0.55. This is a bad value and indicates that NRC is not financially healthy enough and could expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 0.55, NRC is doing worse than 83.17% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.55
Quick Ratio 0.55
NRC Yearly Current Assets VS Current LiabilitesNRC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M

1

3. Growth

3.1 Past

  • The earnings per share for NRC have decreased strongly by -50.56% in the last year.
  • The Earnings Per Share has been growing slightly by 3.24% on average over the past years.
  • The Revenue has decreased by -3.96% in the past year.
  • NRC shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 4.42% yearly.
EPS 1Y (TTM)-50.56%
EPS 3Y-4.7%
EPS 5Y3.24%
EPS Q2Q%-70.57%
Revenue 1Y (TTM)-3.96%
Revenue growth 3Y3.68%
Revenue growth 5Y4.42%
Sales Q2Q%-4.65%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
NRC Yearly Revenue VS EstimatesNRC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M
NRC Yearly EPS VS EstimatesNRC Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2023 0.2 0.4 0.6 0.8 1

5

4. Valuation

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 11.10, the valuation of NRC can be described as very reasonable.
  • Based on the Price/Earnings ratio, NRC is valued cheaply inside the industry as 89.11% of the companies are valued more expensively.
  • NRC's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.13.
Industry RankSector Rank
PE 11.1
Fwd PE N/A
NRC Price Earnings VS Forward Price EarningsNRC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

  • 63.37% of the companies in the same industry are more expensive than NRC, based on the Enterprise Value to EBITDA ratio.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of NRC indicates a somewhat cheap valuation: NRC is cheaper than 63.37% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 19.96
EV/EBITDA 12.86
NRC Per share dataNRC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 6

4.3 Compensation for Growth

  • The excellent profitability rating of NRC may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)3.43
EPS Next 2YN/A
EPS Next 3YN/A

6

5. Dividend

5.1 Amount

  • NRC has a Yearly Dividend Yield of 4.76%, which is a nice return.
  • Compared to an average industry Dividend Yield of 0.48, NRC pays a better dividend. On top of this NRC pays more dividend than 99.01% of the companies listed in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.82, NRC pays a better dividend.
Industry RankSector Rank
Dividend Yield 4.76%

5.2 History

  • The dividend of NRC has a limited annual growth rate of 2.80%.
  • NRC has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)2.8%
Div Incr Years0
Div Non Decr Years0
NRC Yearly Dividends per shareNRC Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1

5.3 Sustainability

  • 94.64% of the earnings are spent on dividend by NRC. This is not a sustainable payout ratio.
  • NRC's earnings are growing around the same pace than its dividend. As long as the earnings growth is kept the dividend growth is sustainable.
DP94.64%
EPS Next 2YN/A
EPS Next 3YN/A
NRC Yearly Income VS Free CF VS DividendNRC Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M
NRC Dividend Payout.NRC Dividend Payout, showing the Payout Ratio.NRC Dividend Payout.PayoutRetained Earnings

NATIONAL RESEARCH CORP

NASDAQ:NRC (3/3/2026, 12:01:05 PM)

13.88

+0.03 (+0.22%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)02-03
Earnings (Next)04-27
Inst Owners49.6%
Inst Owner Change-2.61%
Ins Owners10.45%
Ins Owner Change2.71%
Market Cap314.24M
Revenue(TTM)137.39M
Net Income(TTM)11.60M
Analysts45
Price TargetN/A
Short Float %4.08%
Short Ratio4.57
Dividend
Industry RankSector Rank
Dividend Yield 4.76%
Yearly Dividend0.48
Dividend Growth(5Y)2.8%
DP94.64%
Div Incr Years0
Div Non Decr Years0
Ex-Date03-27
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 11.1
Fwd PE N/A
P/S 2.29
P/FCF 19.96
P/OCF 11.88
P/B 22.46
P/tB N/A
EV/EBITDA 12.86
EPS(TTM)1.25
EY9.01%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.7
FCFY5.01%
OCF(TTM)1.17
OCFY8.42%
SpS6.07
BVpS0.62
TBVpS-2.3
PEG (NY)N/A
PEG (5Y)3.43
Graham Number4.17
Profitability
Industry RankSector Rank
ROA 8.6%
ROE 82.92%
ROCE 22.99%
ROIC 16.19%
ROICexc 16.9%
ROICexgc 56.88%
OM 16.44%
PM (TTM) 8.44%
GM 61.88%
FCFM 11.46%
ROA(3y)17.53%
ROA(5y)20.14%
ROE(3y)75.13%
ROE(5y)62.68%
ROIC(3y)24.89%
ROIC(5y)29.78%
ROICexc(3y)26.43%
ROICexc(5y)39.02%
ROICexgc(3y)111.05%
ROICexgc(5y)N/A
ROCE(3y)35.35%
ROCE(5y)42.3%
ROICexgc growth 3Y-50.84%
ROICexgc growth 5Y-30.78%
ROICexc growth 3Y-34.11%
ROICexc growth 5Y-17.55%
OM growth 3Y-25.59%
OM growth 5Y-12.28%
PM growth 3Y-26.17%
PM growth 5Y-21.27%
GM growth 3Y-0.24%
GM growth 5Y-0.39%
F-Score6
Asset Turnover1.02
Health
Industry RankSector Rank
Debt/Equity 5.36
Debt/FCF 5.02
Debt/EBITDA 2.48
Cap/Depr 140.43%
Cap/Sales 7.79%
Interest Coverage 250
Cash Conversion 87.54%
Profit Quality 135.72%
Current Ratio 0.55
Quick Ratio 0.55
Altman-Z 2.8
F-Score6
WACC7.75%
ROIC/WACC2.09
Cap/Depr(3y)221.48%
Cap/Depr(5y)187.46%
Cap/Sales(3y)9.74%
Cap/Sales(5y)7.88%
Profit Quality(3y)95.08%
Profit Quality(5y)95.51%
High Growth Momentum
Growth
EPS 1Y (TTM)-50.56%
EPS 3Y-4.7%
EPS 5Y3.24%
EPS Q2Q%-70.57%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-3.96%
Revenue growth 3Y3.68%
Revenue growth 5Y4.42%
Sales Q2Q%-4.65%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-36.69%
EBIT growth 3Y-27.99%
EBIT growth 5Y-11.75%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-17.9%
FCF growth 3Y-15.86%
FCF growth 5Y-15.55%
OCF growth 1Y-23.61%
OCF growth 3Y-9.99%
OCF growth 5Y-8.23%

NATIONAL RESEARCH CORP / NRC FAQ

What is the ChartMill fundamental rating of NATIONAL RESEARCH CORP (NRC) stock?

ChartMill assigns a fundamental rating of 5 / 10 to NRC.


Can you provide the valuation status for NATIONAL RESEARCH CORP?

ChartMill assigns a valuation rating of 5 / 10 to NATIONAL RESEARCH CORP (NRC). This can be considered as Fairly Valued.


What is the profitability of NRC stock?

NATIONAL RESEARCH CORP (NRC) has a profitability rating of 8 / 10.


What are the PE and PB ratios of NATIONAL RESEARCH CORP (NRC) stock?

The Price/Earnings (PE) ratio for NATIONAL RESEARCH CORP (NRC) is 11.1 and the Price/Book (PB) ratio is 22.46.


Can you provide the financial health for NRC stock?

The financial health rating of NATIONAL RESEARCH CORP (NRC) is 4 / 10.